Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Tanning bed use, particularly among teen girls and young adult women, has become a modern-day epidemic in the past 20 years. Numerous studies have established the link between indoor tanning use and skin cancer, including melanoma. Reducing the harms of indoor tanning is one of 5 goals outlined in the 2014 US Surgeon General’s “Call to Action to Prevent Skin Cancer.”1 Consistent with the Call to Action, on December 22, 2015, the US Food and Drug Administration (FDA) issued a proposed rule with the following restrictions for sunlamp products (ie, indoor tanning beds and booths): (1) to ban their use among individuals younger than 18 years; (2) to require prospective users to sign a risk acknowledgment certification; and (3) to provide user manuals to customers and tanning facility operators on request.2
Coups EJ, Geller AC, Pagoto SL. The US Food and Drug Administration’s Proposed Rule to Increase Regulation of Indoor Tanning Devices. JAMA Dermatol. 2016;152(5):509–510. doi:10.1001/jamadermatol.2016.0504
Customize your JAMA Network experience by selecting one or more topics from the list below.